Stacey Song

Cooley advised Chemistry, an early-stage venture firm that leads investments in standout software companies at the Seed and Series A stages, on its $350 million debut fund, Chemistry Fund 1.

Cooley advised 20VC, a UK-based firm focused on the intersection of venture capital and media, on the closing of its $400 million third venture capital fund.

Cooley advised PruVen Capital, an independent venture capital firm whose investors are exclusively global leaders in financial services and insurance, on the close of its oversubscribed $378.5 million second fund.

 Cooley advised Industry Ventures, a top investment firm focusing on venture capital, on its $900 million seventh hybrid fund investing in emerging seed and early-stage funds through primary and early secondary limited partnership interests and direct investments.

Cooley advised ChrysCapital, a top India-focused private equity firm, on the close of its oversubscribed $700 million continuation fund and general partner-led secondary transaction to purchase and sell its stake in the National Stock Exchange of India (NSE) with two of the world’s leading secondary fund investors. The landmark transaction is the largest of its kind in India and ranks among the largest in the Asia-Pacific region.